Results 121 to 130 of about 28,394 (188)

A siderurgia portuguesa face à Integração de Portugal na CEE [PDF]

, 1984
Raposeiro, C. A.
core  

Effect of opicapone multiple-dose regimens on levodopa pharmacokinetics. [PDF]

Br J Clin Pharmacol, 2017
Rocha JF, Sicard É, Fauchoux N, Falcão A, Santos A, Loureiro AI, Pinto R, Bonifácio MJ, Nunes T, Almeida L, Soares-da-Silva P.   +10 more
europepmc   +1 more source

Occupational cancer in Spain. [PDF]

Environ Health Perspect, 1999
González CA, Agudo A.
europepmc   +1 more source

Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects. [PDF]

Br J Clin Pharmacol, 2013
Rocha JF, Almeida L, Falcão A, Palma PN, Loureiro AI, Pinto R, Bonifácio MJ, Wright LC, Nunes T, Soares-da-Silva P.   +9 more
europepmc   +1 more source

Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP. [PDF]

Clin Cancer Res, 2012
Yin S, Kaluz S, Devi NS, Jabbar AA, de Noronha RG, Mun J, Zhang Z, Boreddy PR, Wang W, Wang Z, Abbruscato T, Chen Z, Olson JJ, Zhang R, Goodman MM, Nicolaou KC, Van Meir EG.   +16 more
europepmc   +1 more source

Dos puntualizaciones sobre la historia de la siderurgia española entre 1880 y 1930 [PDF]

, 1999
Escudero, Antonio
core  

Eslicarbazepine acetate (BIA 2-093). [PDF]

Neurotherapeutics, 2007
Almeida L, Soares-da-Silva P.
europepmc   +1 more source

Manuel Corbera Millán, La siderurgia tradional en Cantabria [PDF]

, 2002
Carrión Arregui, Ignacio
core  

Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action. [PDF]

Pharmacol Res Perspect, 2015
Soares-da-Silva P, Pires N, Bonifácio MJ, Loureiro AI, Palma N, Wright LC.   +5 more
europepmc   +1 more source

Sargadelos en la historia de la siderurgia española [PDF]

, 1993
Carmona Badía, Xoán
core